Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,308 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Factors related to nocturia-specific quality of life in renal transplantation patients.
Nakamura N, Emoto T, Fukuhara Y, Miyazaki T, Aoyagi C, Gunge N, Okabe Y, Matsuzaki H, Fujikawa A, Nakagawa C, Tachibana M, Yamasaki F, Tominaga K, Tsubouchi K, Aso S, Haga N. Nakamura N, et al. Among authors: tachibana m. Low Urin Tract Symptoms. 2024 May;16(3):e12517. doi: 10.1111/luts.12517. Low Urin Tract Symptoms. 2024. PMID: 38693053
Drugs Showing Real-world Efficacy for Nocturia in Patients With Bladder Storage Symptoms.
Tsubouchi K, Gunge N, Matsuoka W, Emoto T, Miyazaki T, Tominaga K, Okabe YU, Matsuzaki H, Aso S, Tachibana M, Nakagawa C, Fujikawa A, Nakamura N, Matsuoka H, Haga N. Tsubouchi K, et al. Among authors: tachibana m. Anticancer Res. 2023 Jan;43(1):455-461. doi: 10.21873/anticanres.16182. Anticancer Res. 2023. PMID: 36585172
Efficacy and Safety of Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Therapy for Anemia in Renal Transplantation Patients by Prior Erythropoiesis Stimulating Agent Use.
Nakamura N, Aso S, Nakagawa C, Tachibana M, Fujikawa A, Tsubouchi K, Gunge N, Miyazaki T, Okabe Y, Matsuzaki H, Matsuoka H, Haga N. Nakamura N, et al. Among authors: tachibana m. Transplant Proc. 2023 May;55(4):829-831. doi: 10.1016/j.transproceed.2023.03.062. Epub 2023 Apr 25. Transplant Proc. 2023. PMID: 37105829
Factors Related to Overactive Bladder-like Symptoms in Bladder Cancer.
Tachibana M, Tsubouchi K, Fukuhara Y, Aoyagi C, Tominaga K, Gunge N, Okabe YU, Miyazaki T, Emoto T, Nakagawa C, Yamazaki F, Matsuzaki H, Nakamura N, Haga N. Tachibana M, et al. Anticancer Res. 2023 Aug;43(8):3607-3613. doi: 10.21873/anticanres.16540. Anticancer Res. 2023. PMID: 37500156
Identification of risk factors associated with oral 5-aminolevulinic acid induced adverse events in photodynamic diagnosis-transurethral resection of bladder tumor.
Okabe Y, Fukuhara Y, Matsuoka W, Nakamura N, Matsuzaki H, Miyazaki T, Gunge N, Tominaga K, Tsubouchi K, Tachibana M, Nakagawa C, Yamazaki F, Haga N. Okabe Y, et al. Among authors: tachibana m. Photodiagnosis Photodyn Ther. 2024 Oct;49:104291. doi: 10.1016/j.pdpdt.2024.104291. Epub 2024 Jul 24. Photodiagnosis Photodyn Ther. 2024. PMID: 39059758 Free article.
The Mayo Adhesive Probability Score as a Predictor of Postoperative Renal Function in Robot-assisted Partial Nephrectomy.
Matsuzaki H, Tsubouchi K, Okabe YU, Miyazaki T, Gunge N, Tominaga K, Fukuhara Y, Tachibana M, Nakagawa C, Yamazaki F, Nakamura N, Haga N. Matsuzaki H, et al. Among authors: tachibana m. Cancer Diagn Progn. 2024 Sep 1;4(5):652-657. doi: 10.21873/cdp.10377. eCollection 2024 Sep-Oct. Cancer Diagn Progn. 2024. PMID: 39238623 Free PMC article.
Correction: Targeted deep sequencing analyses of long QT syndrome in a Japanese population.
Nagata Y, Watanabe R, Eichhorn C, Ohno S, Aiba T, Ishikawa T, Nakano Y, Aizawa Y, Hayashi K, Murakoshi N, Nakajima T, Yagihara N, Mishima H, Sudo T, Higuchi C, Takahashi A, Sekine A, Makiyama T, Tanaka Y, Watanabe A, Tachibana M, Morita H, Yoshiura KI, Tsunoda T, Watanabe H, Kurabayashi M, Nogami A, Kihara Y, Horie M, Shimizu W, Makita N, Tanaka T. Nagata Y, et al. Among authors: tachibana m. PLoS One. 2024 Dec 3;19(12):e0315106. doi: 10.1371/journal.pone.0315106. eCollection 2024. PLoS One. 2024. PMID: 39625945 Free article.
Valemetostat monotherapy in patients with relapsed or refractory non-Hodgkin lymphoma: a first-in-human, multicentre, open-label, single-arm, phase 1 study.
Maruyama D, Jacobsen E, Porcu P, Allen P, Ishitsuka K, Kusumoto S, Narita T, Tobinai K, Foss F, Tsukasaki K, Feldman T, Imaizumi Y, Izutsu K, Morishima S, Yamauchi N, Yuda J, Brammer JE, Kawamata T, Ruan J, Nosaka K, Utsunomiya A, Wang J, Zain J, Kakurai Y, Yamauchi H, Hizukuri Y, Biserna N, Tachibana M, Inoue A, Horwitz SM. Maruyama D, et al. Among authors: tachibana m. Lancet Oncol. 2024 Oct 29:S1470-2045(24)00502-3. doi: 10.1016/S1470-2045(24)00502-3. Online ahead of print. Lancet Oncol. 2024. PMID: 39486432
1,308 results